Green Alpha Advisors’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $103K | Sell |
11,007
-1,461
| -12% | -$13.7K | 0.1% | 101 |
|
|
2025
Q1 | $88.6K | Buy |
12,468
+669
| +6% | +$4.76K | 0.09% | 104 |
|
|
2024
Q4 | $138K | Buy |
+11,799
| New | +$138K | 0.11% | 139 |
|
|
2024
Q2 | – | Sell |
-7,964
| Closed | -$219K | – | 141 |
|
|
2024
Q1 | $219K | Sell |
7,964
-2,139
| -21% | -$58.8K | 0.16% | 129 |
|
|
2023
Q4 | $308K | Sell |
10,103
-4,674
| -32% | -$143K | 0.22% | 131 |
|
|
2023
Q3 | $467K | Sell |
14,777
-314
| -2% | -$9.93K | 0.36% | 94 |
|
|
2023
Q2 | $615K | Buy |
15,091
+1,187
| +9% | +$48.4K | 0.4% | 96 |
|
|
2023
Q1 | $518K | Sell |
13,904
-1,467
| -10% | -$54.7K | 0.36% | 103 |
|
|
2022
Q4 | $536K | Buy |
15,371
+813
| +6% | +$28.4K | 0.45% | 89 |
|
|
2022
Q3 | $815K | Sell |
14,558
-67,941
| -82% | -$3.8M | 0.69% | 60 |
|
|
2022
Q2 | $4.27M | Buy |
82,499
+71,748
| +667% | +$3.71M | 0.98% | 33 |
|
|
2022
Q1 | $781K | Buy |
10,751
+1,617
| +18% | +$117K | 0.53% | 82 |
|
|
2021
Q4 | $1.08M | Buy |
9,134
+248
| +3% | +$29.3K | 0.73% | 61 |
|
|
2021
Q3 | $1.19M | Sell |
8,886
-370
| -4% | -$49.6K | 0.82% | 47 |
|
|
2021
Q2 | $1.5M | Sell |
9,256
-738
| -7% | -$120K | 1.02% | 34 |
|
|
2021
Q1 | $802K | Buy |
9,994
+5,255
| +111% | +$422K | 0.79% | 53 |
|
|
2020
Q4 | $258K | Buy |
+4,739
| New | +$258K | 0.31% | 90 |
|